Group Psychoeducational Treatment for Women With Sexual Arousal Difficulties, Phase II
Group PED
Group PED
Sponsor study identifier
interventional
98
1 country
2
Study Start
November 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2012
Actual (reported)Study Completion
June 2012
Actual (reported)The purpose of this study is to pilot test and determine the efficacy of a psychoeducational intervention (PED) we recently piloted in a group format for women with acquired sexual arousal disorder (FSAD). HYPOTHESES:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2012
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2007
Date type not reportedThis date has not been verified as actual or estimated.
October 29, 2010
Actual (reported)June 2012
Actual (reported)June 2012
Actual (reported)October 15, 2012
Actual (reported)Change in physiological sexual arousal
Sexual arousal will be measured physiologically with a Vaginal Photoplethysmograph (VPP). The VPP measures vaginal pulse amplitude (VPA) which has been found to be a sensitive and specific measure of genital arousal (Laan \& Everaerd, 1995).
Sexual arousal will be measured approximately one week pre-treatment and approxiately two weeks post-treatment
Long-term change in physiological sexual arousal
Sexual arousal will be measured physiologically with a Vaginal Photoplethysmograph (VPP). The VPP measures vaginal pulse amplitude (VPA) which has been found to be a sensitive and specific measure of genital arousal (Laan \& Everaerd, 1995).
Sexual arousal will be assessed approximately one-week pre-treatment and approximately 6 months post treatment
Subjective sexual arousal
Subjective sexual arousal will be assessed approximately one week pre-treatment, approximately two-weeks post-treatment and approximately 6-months post treatment
Sexual Distress
Sexual distress will be assessed approximately one week pre-treatment, approximatley two weeks post-treatment and approximately 6-months post-treatment
Mood
Mood will be assessed approximately one week pre-treatment, approximatley two weeks post-treatment and approximately 6-months post-treatment
Women randomized into the "treatment" group will undergo pre-treatment testing (questionnaires and physiological assessment)within 14 days of beginning treatment
Women randomized to the "waitlist" group will undergo initial testing (questionnaires and physiological testing) and receive no treatment until the next scheduled group (4 months). They will undergo pretreatment testing and treatment on the same schedule as women in the "treatment" group.
four 1.5 hour long group psychoeducational sessions, spaced 2 weeks apart for a total of 8 weeks.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
BC Centre for Sexual Medicine
Vancouver, British Columbia, V5Z 1C6, Canada
UBC Sexual Health Lab, Vancouver Hospital
Vancouver, British Columbia, V5Z 1M9, Canada
Lori A Brotto, PhD
University of British Columbia
98 participants (actual enrollment reported by the registry).
First Submitted
October 29, 2010
First Posted
October 15, 2012
Study Start
November 2007
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
June 2012
Actual (reported)Study Completion
June 2012
Actual (reported)Last Updated
June 1, 2017
Record last verified: 2017-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: